StocktoriaNewGenIvf Group Ltd NIVF
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC
Chart by TradingView
3/9
Piotroski F — financial health
3.84
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $23.7M | $5.4M | $5.1M | $506,343 |
| Gross profit | $955,846 | $1.8M | $1.7M | $1.5M |
| Operating income | -$10.7M | -$1.2M | $42,242 | $398,705 |
| Net income | $9.9M | -$524,643 | $130,193 | $458,667 |
| Operating cash flow | -$10.9M | -$8.3M | -$1.8M | $1.7M |
| Free cash flow | -$11.1M | -$8.3M | -$1.8M | $1.6M |
| Total assets | $32.7M | $3.6M | $4.5M | $2.9M |
| Total liabilities | $6.7M | $5.1M | $1.2M | $2.8M |
| Shareholders' equity | $26.6M | -$1.5M | $3.2M | $100,683 |
| Ratios | ||||
| Gross margin | 4.0% | 33.6% | 32.7% | — |
| Operating margin | -45.2% | -21.4% | 0.8% | 78.7% |
| Net margin | 41.7% | -9.7% | 2.5% | 90.6% |
| FCF margin | -46.7% | -153.1% | -35.7% | 319.2% |
| Return on assets | 30.2% | -14.7% | 2.9% | 15.8% |
| Return on equity | 37.1% | 35.4% | 4.0% | 455.6% |
| Current ratio | 3.12 | 1.17 | 2.19 | 0.94 |
| Revenue growth | 336.3% | 5.8% | 914.4% | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.84 (safe)
- Working capital / assets 0.153
- Retained earnings / assets 0.272
- EBIT / assets -0.328
- Equity / liabilities 3.954
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001981662 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.